Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 January 2021 | Story Leonie Bolleurs | Photo Supplied
Dr Ria de Villiers is passionate about education as a vehicle to ensure that people are fully engaged in work and life.

The world is rapidly changing, and the Department of Education (DBE) is responding with a plan that aims to prepare learners to adapt to a new world. Ecubed (E3), a DBE programme using playful project-based learning as a learning methodology, unlocks an entrepreneurial mindset in school learners. The E3 programme focuses on entrepreneurship, employability, and education, emphasising learning as a lifelong process. Dr Ria de Villiers is the Curriculum and Schools’ Implementation Manager for E3.

Dr De Villiers, an alumna of the University of the Free State (UFS), is passionate about education as a vehicle to unlock competencies and agency, ensuring that people are fully engaged in work and life. Dr De Villiers therefore invests great effort in contributing to a more relevant education system. “I feel compelled to do something about the challenges we see in education, especially since it is such a vital part of our human (and societal) development,” she says. 

Loving the buzz at schools, the smell of dust and chalk, Dr De Villiers really has a heart for teachers. “Teachers are often unacknowledged, and the work they do is critical,” she believes. She realised that as a teacher, her reach was too small to solve the problems in the South African education system. Therefore, she works as a teacher trainer, where she feels she can have a broader impact.

Her work as implementation manager for E3 allows her to make a positive impact on the education sector, while managing the creation of new learning materials online and face to face, as well as working in teacher development.

The difference in a changed world

Talking about E3, she says the programme prepares learners to acquire skills, knowledge, attitude, and mindset to be business owners or employers while being lifelong learners. The traditional way of teaching is changing, and with skills acquired through the E3 programme, school leavers will be ready to attend a tertiary institution, be prepared for the job market, and/or be able to start a business.

This is not the first time that Dr De Villiers has found herself in the education arena. She received her doctorate in Applied Linguistics from the UFS Faculty of the Humanities under the supervision of Prof Willfred Greyling in the Department of English. Her dissertation was titled, The impact of a discourse-based teacher counselling model in training language teachers for outcomes-based education. Assisting government and teacher unions with the training of teachers helped her to obtain the data for her PhD, in which she proposed a teacher-counselling model to promote teacher efficacy and agency. 

Teaching across borders

A big part of her career was spent in the education environment, although she worked as a businesswoman and freelance consultant for more than 30 years – first as teacher and university lecturer, and later as co-founder of Future Entrepreneurs, a publishing and teacher-support business. 

But it was when she started a language school that her communication business, Jika Communication and Training, came into being; it was not long before this enterprise developed into a leading training organisation for entrepreneurship education programmes endorsed by the International Labour Organisation (ILO). Together with the ILO, she worked on a series of 30 business simulation games and role-plays to promote progressive teaching methodologies, learner-centredness, and activity-based experiential learning. 

Teaching others about learning also allowed Dr De Villiers to cross South African borders when she facilitated the reworking of the vocational curriculum for the Indonesian government. She has done training at all teacher-training colleges in Dar-es-Salaam and Zanzibar for the Ministry of Education in Tanzania. 

A more humane, learner-centred approach

In our changing world, and as it pertains to the education system, Dr De Villiers truly believes that training and teaching needs a more humane, learner-centred approach, with mutual respect between trainer and learner. 

She remains inspired to continue making a difference in the sector. “I want schooling to improve and gear itself for a rapidly changing world. I want young people who are out of work to find their voice and place in the economy. I want every school learner to develop the agency and confidence to stand up in class and ask a question without any fear of losing face. And I want teachers to develop that agency too as they become more and more autonomous, self-reliant, and confident enough to teach using progressive methodologies.”

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept